4516.T · 日本新薬
Japan · RS rating 12 · As of 2026-10-14
| Price | 3,331.00 JPY |
|---|---|
| 1-day change | -2.2% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 57 / 6 / 49 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 5 / 36 |
| Industry group (rank) | Finance-Investment Mgmt (28) |
| EPS growth Q/Q | +22.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +44.9% |
| Market cap (USD) | $1.4B |